Akero Therapeutics Inc (NASDAQ:AKRO) has a beta value of -0.31 and has seen 1.54 million shares traded in the last trading session. The company, currently valued at $1.59B, closed the last trade at $23.02 per share which meant it gained $1.69 on the day or 7.92% during that session. The AKRO stock price is -153.61% off its 52-week high price of $58.38 and 51.13% above the 52-week low of $11.25. The 3-month trading volume is 966.73K shares.
Akero Therapeutics Inc (NASDAQ:AKRO) trade information
Sporting 7.92% in the green in last session, the stock has traded in the green over the last five days, when the AKRO stock price touched $23.02 or saw a rise of 5.62%. Year-to-date, Akero Therapeutics Inc shares have moved -1.41%, while the 5-day performance has seen it change 22.32%. Over the past 30 days, the shares of Akero Therapeutics Inc (NASDAQ:AKRO) have changed 9.51%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Akero Therapeutics Inc (AKRO) estimates and forecasts
Figures show that Akero Therapeutics Inc shares have underperformed across the wider relevant industry. The company’s shares have gained 20.78% over the past 6 months, with this year growth rate of -33.91%, compared to 15.30% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 1.03% over the past 5 years.
AKRO Dividends
Akero Therapeutics Inc is expected to release its next earnings report in July this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
